nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Rash papular—Hyoscyamine—pancreatitis	0.00876	0.133	CcSEcCtD
Bosutinib—Rash macular—Hyoscyamine—pancreatitis	0.00795	0.121	CcSEcCtD
Bosutinib—PHKG1—exocrine gland—pancreatitis	0.00707	0.0223	CbGeAlD
Bosutinib—SRMS—gall bladder—pancreatitis	0.00582	0.0184	CbGeAlD
Bosutinib—STK26—gall bladder—pancreatitis	0.00549	0.0173	CbGeAlD
Bosutinib—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00508	0.077	CcSEcCtD
Bosutinib—CLK3—islet of Langerhans—pancreatitis	0.00399	0.0126	CbGeAlD
Bosutinib—ERBB3—exocrine gland—pancreatitis	0.00386	0.0122	CbGeAlD
Bosutinib—PTK2—exocrine gland—pancreatitis	0.00374	0.0118	CbGeAlD
Bosutinib—VRK2—islet of Langerhans—pancreatitis	0.00374	0.0118	CbGeAlD
Bosutinib—WEE1—islet of Langerhans—pancreatitis	0.00345	0.0109	CbGeAlD
Bosutinib—Respiratory failure—Hyoscyamine—pancreatitis	0.00332	0.0504	CcSEcCtD
Bosutinib—PLK2—islet of Langerhans—pancreatitis	0.0032	0.0101	CbGeAlD
Bosutinib—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00296	0.045	CcSEcCtD
Bosutinib—CLK3—pancreas—pancreatitis	0.0028	0.00885	CbGeAlD
Bosutinib—VRK2—pancreas—pancreatitis	0.00263	0.00829	CbGeAlD
Bosutinib—STK26—pancreas—pancreatitis	0.00253	0.00798	CbGeAlD
Bosutinib—STK33—digestive system—pancreatitis	0.00252	0.00794	CbGeAlD
Bosutinib—MAP4K4—islet of Langerhans—pancreatitis	0.00249	0.00787	CbGeAlD
Bosutinib—NUAK2—islet of Langerhans—pancreatitis	0.00248	0.00781	CbGeAlD
Bosutinib—BCR—islet of Langerhans—pancreatitis	0.00248	0.00781	CbGeAlD
Bosutinib—TLK1—blood—pancreatitis	0.00247	0.00778	CbGeAlD
Bosutinib—PRKCQ—blood—pancreatitis	0.00243	0.00767	CbGeAlD
Bosutinib—WEE1—pancreas—pancreatitis	0.00242	0.00764	CbGeAlD
Bosutinib—STK35—islet of Langerhans—pancreatitis	0.00241	0.0076	CbGeAlD
Bosutinib—CLK3—digestive system—pancreatitis	0.00239	0.00756	CbGeAlD
Bosutinib—CSK—islet of Langerhans—pancreatitis	0.00239	0.00755	CbGeAlD
Bosutinib—CSNK1A1—islet of Langerhans—pancreatitis	0.00238	0.0075	CbGeAlD
Bosutinib—CLK1—islet of Langerhans—pancreatitis	0.00236	0.00745	CbGeAlD
Bosutinib—EPHB2—digestive system—pancreatitis	0.00234	0.00738	CbGeAlD
Bosutinib—PKMYT1—blood—pancreatitis	0.00234	0.00737	CbGeAlD
Bosutinib—STK25—pancreas—pancreatitis	0.00231	0.0073	CbGeAlD
Bosutinib—SRMS—digestive system—pancreatitis	0.00229	0.00723	CbGeAlD
Bosutinib—BMX—blood—pancreatitis	0.00228	0.0072	CbGeAlD
Bosutinib—CLK3—blood—pancreatitis	0.00228	0.0072	CbGeAlD
Bosutinib—Anaphylactic shock—Propantheline—pancreatitis	0.00227	0.0345	CcSEcCtD
Bosutinib—BLK—blood—pancreatitis	0.00226	0.00712	CbGeAlD
Bosutinib—PLK2—pancreas—pancreatitis	0.00225	0.0071	CbGeAlD
Bosutinib—EIF2AK1—blood—pancreatitis	0.00221	0.00696	CbGeAlD
Bosutinib—CSNK1E—islet of Langerhans—pancreatitis	0.0022	0.00695	CbGeAlD
Bosutinib—Dehydration—Hyoscyamine—pancreatitis	0.0022	0.0334	CcSEcCtD
Bosutinib—SYK—digestive system—pancreatitis	0.0022	0.00694	CbGeAlD
Bosutinib—CDK2—digestive system—pancreatitis	0.00218	0.00688	CbGeAlD
Bosutinib—SIK1—islet of Langerhans—pancreatitis	0.00217	0.00684	CbGeAlD
Bosutinib—IRAK4—islet of Langerhans—pancreatitis	0.00217	0.00684	CbGeAlD
Bosutinib—STK26—digestive system—pancreatitis	0.00216	0.00682	CbGeAlD
Bosutinib—TXK—blood—pancreatitis	0.00216	0.00681	CbGeAlD
Bosutinib—FES—blood—pancreatitis	0.00214	0.00675	CbGeAlD
Bosutinib—VRK2—blood—pancreatitis	0.00214	0.00675	CbGeAlD
Bosutinib—CAMK1D—pancreas—pancreatitis	0.00212	0.0067	CbGeAlD
Bosutinib—MAP2K2—islet of Langerhans—pancreatitis	0.00212	0.00669	CbGeAlD
Bosutinib—TNIK—blood—pancreatitis	0.0021	0.00661	CbGeAlD
Bosutinib—SYK—blood—pancreatitis	0.0021	0.00661	CbGeAlD
Bosutinib—CDK2—blood—pancreatitis	0.00208	0.00655	CbGeAlD
Bosutinib—DMPK—digestive system—pancreatitis	0.00207	0.00653	CbGeAlD
Bosutinib—WEE1—digestive system—pancreatitis	0.00207	0.00653	CbGeAlD
Bosutinib—TBK1—islet of Langerhans—pancreatitis	0.00206	0.00651	CbGeAlD
Bosutinib—PTK2—islet of Langerhans—pancreatitis	0.00206	0.00651	CbGeAlD
Bosutinib—STK26—blood—pancreatitis	0.00206	0.00649	CbGeAlD
Bosutinib—IRAK1—islet of Langerhans—pancreatitis	0.00202	0.00638	CbGeAlD
Bosutinib—CHEK2—blood—pancreatitis	0.00199	0.00627	CbGeAlD
Bosutinib—STK25—digestive system—pancreatitis	0.00198	0.00623	CbGeAlD
Bosutinib—DMPK—blood—pancreatitis	0.00197	0.00622	CbGeAlD
Bosutinib—WEE1—blood—pancreatitis	0.00197	0.00622	CbGeAlD
Bosutinib—PDGFRB—gall bladder—pancreatitis	0.00194	0.00611	CbGeAlD
Bosutinib—PLK2—digestive system—pancreatitis	0.00192	0.00606	CbGeAlD
Bosutinib—SLK—islet of Langerhans—pancreatitis	0.00189	0.00596	CbGeAlD
Bosutinib—STK25—blood—pancreatitis	0.00188	0.00594	CbGeAlD
Bosutinib—EPHB4—islet of Langerhans—pancreatitis	0.00188	0.00592	CbGeAlD
Bosutinib—Feeling abnormal—Propantheline—pancreatitis	0.00187	0.0284	CcSEcCtD
Bosutinib—EPHA2—islet of Langerhans—pancreatitis	0.00184	0.00581	CbGeAlD
Bosutinib—STK4—digestive system—pancreatitis	0.00184	0.00579	CbGeAlD
Bosutinib—PLK2—blood—pancreatitis	0.00183	0.00577	CbGeAlD
Bosutinib—Urticaria—Propantheline—pancreatitis	0.00181	0.0274	CcSEcCtD
Bosutinib—MAP4K5—islet of Langerhans—pancreatitis	0.0018	0.00567	CbGeAlD
Bosutinib—MAP4K4—pancreas—pancreatitis	0.00175	0.00553	CbGeAlD
Bosutinib—STK4—blood—pancreatitis	0.00175	0.00552	CbGeAlD
Bosutinib—NUAK2—pancreas—pancreatitis	0.00174	0.00549	CbGeAlD
Bosutinib—ALK—digestive system—pancreatitis	0.00174	0.00548	CbGeAlD
Bosutinib—EPHA5—digestive system—pancreatitis	0.00174	0.00548	CbGeAlD
Bosutinib—CAMK1D—blood—pancreatitis	0.00173	0.00546	CbGeAlD
Bosutinib—STK24—blood—pancreatitis	0.00171	0.00539	CbGeAlD
Bosutinib—STK35—pancreas—pancreatitis	0.00169	0.00534	CbGeAlD
Bosutinib—CSK—pancreas—pancreatitis	0.00168	0.00531	CbGeAlD
Bosutinib—CSNK1A1—pancreas—pancreatitis	0.00167	0.00527	CbGeAlD
Bosutinib—CLK1—pancreas—pancreatitis	0.00166	0.00524	CbGeAlD
Bosutinib—YES1—islet of Langerhans—pancreatitis	0.00166	0.00523	CbGeAlD
Bosutinib—FER—blood—pancreatitis	0.00165	0.00522	CbGeAlD
Bosutinib—ALK—blood—pancreatitis	0.00165	0.00522	CbGeAlD
Bosutinib—LYN—blood—pancreatitis	0.00165	0.00519	CbGeAlD
Bosutinib—TAOK3—islet of Langerhans—pancreatitis	0.00164	0.00517	CbGeAlD
Bosutinib—Asthenia—Propantheline—pancreatitis	0.00163	0.0247	CcSEcCtD
Bosutinib—CAMK2G—pancreas—pancreatitis	0.00163	0.00514	CbGeAlD
Bosutinib—MAP4K1—blood—pancreatitis	0.00162	0.00511	CbGeAlD
Bosutinib—BTK—blood—pancreatitis	0.00161	0.00509	CbGeAlD
Bosutinib—ROCK1—digestive system—pancreatitis	0.0016	0.00505	CbGeAlD
Bosutinib—SRC—islet of Langerhans—pancreatitis	0.0016	0.00503	CbGeAlD
Bosutinib—MAP4K2—blood—pancreatitis	0.00157	0.00494	CbGeAlD
Bosutinib—BMPR2—digestive system—pancreatitis	0.00156	0.00491	CbGeAlD
Bosutinib—CSNK1E—pancreas—pancreatitis	0.00155	0.00489	CbGeAlD
Bosutinib—STK3—blood—pancreatitis	0.00155	0.00488	CbGeAlD
Bosutinib—EPHB3—digestive system—pancreatitis	0.00154	0.00487	CbGeAlD
Bosutinib—ROCK1—blood—pancreatitis	0.00153	0.00481	CbGeAlD
Bosutinib—SIK1—pancreas—pancreatitis	0.00152	0.00481	CbGeAlD
Bosutinib—Dizziness—Propantheline—pancreatitis	0.0015	0.0228	CcSEcCtD
Bosutinib—MAP4K4—digestive system—pancreatitis	0.0015	0.00472	CbGeAlD
Bosutinib—ERBB3—pancreas—pancreatitis	0.00149	0.00471	CbGeAlD
Bosutinib—MAP2K2—pancreas—pancreatitis	0.00149	0.0047	CbGeAlD
Bosutinib—STK36—blood—pancreatitis	0.00147	0.00464	CbGeAlD
Bosutinib—MERTK—blood—pancreatitis	0.00145	0.00458	CbGeAlD
Bosutinib—TBK1—pancreas—pancreatitis	0.00145	0.00457	CbGeAlD
Bosutinib—PTK2—pancreas—pancreatitis	0.00145	0.00457	CbGeAlD
Bosutinib—MAP2K1—digestive system—pancreatitis	0.00145	0.00456	CbGeAlD
Bosutinib—Vomiting—Propantheline—pancreatitis	0.00145	0.0219	CcSEcCtD
Bosutinib—CSK—digestive system—pancreatitis	0.00144	0.00453	CbGeAlD
Bosutinib—Rash—Propantheline—pancreatitis	0.00143	0.0217	CcSEcCtD
Bosutinib—Dermatitis—Propantheline—pancreatitis	0.00143	0.0217	CcSEcCtD
Bosutinib—CSNK1A1—digestive system—pancreatitis	0.00143	0.0045	CbGeAlD
Bosutinib—MAP4K4—blood—pancreatitis	0.00143	0.0045	CbGeAlD
Bosutinib—Headache—Propantheline—pancreatitis	0.00142	0.0216	CcSEcCtD
Bosutinib—IRAK1—pancreas—pancreatitis	0.00142	0.00448	CbGeAlD
Bosutinib—HCK—digestive system—pancreatitis	0.00142	0.00447	CbGeAlD
Bosutinib—CLK1—digestive system—pancreatitis	0.00142	0.00447	CbGeAlD
Bosutinib—NUAK2—blood—pancreatitis	0.00142	0.00447	CbGeAlD
Bosutinib—BCR—blood—pancreatitis	0.00142	0.00447	CbGeAlD
Bosutinib—MAP3K12—blood—pancreatitis	0.00141	0.00444	CbGeAlD
Bosutinib—Dysgeusia—Hyoscyamine—pancreatitis	0.0014	0.0212	CcSEcCtD
Bosutinib—RPS6KB1—pancreas—pancreatitis	0.00139	0.0044	CbGeAlD
Bosutinib—CAMK2G—digestive system—pancreatitis	0.00139	0.00439	CbGeAlD
Bosutinib—MAP2K1—blood—pancreatitis	0.00138	0.00435	CbGeAlD
Bosutinib—CSK—blood—pancreatitis	0.00137	0.00432	CbGeAlD
Bosutinib—CSNK1A1—blood—pancreatitis	0.00136	0.00429	CbGeAlD
Bosutinib—HCK—blood—pancreatitis	0.00135	0.00426	CbGeAlD
Bosutinib—CLK1—blood—pancreatitis	0.00135	0.00426	CbGeAlD
Bosutinib—Nausea—Propantheline—pancreatitis	0.00135	0.0205	CcSEcCtD
Bosutinib—PTK2B—digestive system—pancreatitis	0.00134	0.00424	CbGeAlD
Bosutinib—ABL2—blood—pancreatitis	0.00134	0.00424	CbGeAlD
Bosutinib—SLK—pancreas—pancreatitis	0.00133	0.00419	CbGeAlD
Bosutinib—BMP2K—blood—pancreatitis	0.00133	0.00418	CbGeAlD
Bosutinib—CAMK2G—blood—pancreatitis	0.00133	0.00418	CbGeAlD
Bosutinib—CSNK1E—digestive system—pancreatitis	0.00132	0.00417	CbGeAlD
Bosutinib—EPHB4—pancreas—pancreatitis	0.00132	0.00416	CbGeAlD
Bosutinib—LRRK2—blood—pancreatitis	0.00131	0.00415	CbGeAlD
Bosutinib—EPHA2—pancreas—pancreatitis	0.00129	0.00408	CbGeAlD
Bosutinib—PTK2B—blood—pancreatitis	0.00128	0.00404	CbGeAlD
Bosutinib—ERBB3—digestive system—pancreatitis	0.00128	0.00403	CbGeAlD
Bosutinib—ULK3—digestive system—pancreatitis	0.00127	0.00402	CbGeAlD
Bosutinib—MAP2K2—digestive system—pancreatitis	0.00127	0.00402	CbGeAlD
Bosutinib—PDGFRB—islet of Langerhans—pancreatitis	0.00127	0.00401	CbGeAlD
Bosutinib—MAP4K5—pancreas—pancreatitis	0.00126	0.00398	CbGeAlD
Bosutinib—CSNK1E—blood—pancreatitis	0.00126	0.00398	CbGeAlD
Bosutinib—IRAK4—blood—pancreatitis	0.00124	0.00391	CbGeAlD
Bosutinib—SIK1—blood—pancreatitis	0.00124	0.00391	CbGeAlD
Bosutinib—TBK1—digestive system—pancreatitis	0.00124	0.00391	CbGeAlD
Bosutinib—PTK2—digestive system—pancreatitis	0.00124	0.00391	CbGeAlD
Bosutinib—EPHA4—blood—pancreatitis	0.00123	0.00387	CbGeAlD
Bosutinib—Chest pain—Hyoscyamine—pancreatitis	0.00121	0.0184	CcSEcCtD
Bosutinib—ULK3—blood—pancreatitis	0.00121	0.00383	CbGeAlD
Bosutinib—MAP2K2—blood—pancreatitis	0.00121	0.00383	CbGeAlD
Bosutinib—MAP3K2—blood—pancreatitis	0.0012	0.0038	CbGeAlD
Bosutinib—MAP3K7—blood—pancreatitis	0.00119	0.00376	CbGeAlD
Bosutinib—RPS6KB1—digestive system—pancreatitis	0.00119	0.00376	CbGeAlD
Bosutinib—FGR—digestive system—pancreatitis	0.00118	0.00373	CbGeAlD
Bosutinib—PTK2—blood—pancreatitis	0.00118	0.00372	CbGeAlD
Bosutinib—TBK1—blood—pancreatitis	0.00118	0.00372	CbGeAlD
Bosutinib—YES1—pancreas—pancreatitis	0.00117	0.00368	CbGeAlD
Bosutinib—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00116	0.0176	CcSEcCtD
Bosutinib—Oedema—Hyoscyamine—pancreatitis	0.00116	0.0176	CcSEcCtD
Bosutinib—IRAK1—blood—pancreatitis	0.00116	0.00365	CbGeAlD
Bosutinib—TAOK3—pancreas—pancreatitis	0.00115	0.00363	CbGeAlD
Bosutinib—RPS6KB1—blood—pancreatitis	0.00113	0.00358	CbGeAlD
Bosutinib—ABL1—islet of Langerhans—pancreatitis	0.00113	0.00357	CbGeAlD
Bosutinib—LCK—blood—pancreatitis	0.00113	0.00356	CbGeAlD
Bosutinib—FGR—blood—pancreatitis	0.00113	0.00356	CbGeAlD
Bosutinib—EPHB4—digestive system—pancreatitis	0.00113	0.00355	CbGeAlD
Bosutinib—SRC—pancreas—pancreatitis	0.00112	0.00354	CbGeAlD
Bosutinib—EPHA2—digestive system—pancreatitis	0.00111	0.00349	CbGeAlD
Bosutinib—FYN—digestive system—pancreatitis	0.0011	0.00348	CbGeAlD
Bosutinib—SLK—blood—pancreatitis	0.00108	0.00341	CbGeAlD
Bosutinib—EPHB4—blood—pancreatitis	0.00107	0.00339	CbGeAlD
Bosutinib—EPHA2—blood—pancreatitis	0.00105	0.00332	CbGeAlD
Bosutinib—FYN—blood—pancreatitis	0.00105	0.00332	CbGeAlD
Bosutinib—Dyspnoea—Hyoscyamine—pancreatitis	0.00104	0.0157	CcSEcCtD
Bosutinib—MAP4K5—blood—pancreatitis	0.00103	0.00324	CbGeAlD
Bosutinib—MAP3K3—blood—pancreatitis	0.00103	0.00324	CbGeAlD
Bosutinib—Fatigue—Hyoscyamine—pancreatitis	0.001	0.0152	CcSEcCtD
Bosutinib—YES1—digestive system—pancreatitis	0.000996	0.00314	CbGeAlD
Bosutinib—Pain—Hyoscyamine—pancreatitis	0.000995	0.0151	CcSEcCtD
Bosutinib—STK10—digestive system—pancreatitis	0.000987	0.00311	CbGeAlD
Bosutinib—TAOK3—digestive system—pancreatitis	0.000983	0.0031	CbGeAlD
Bosutinib—Feeling abnormal—Hyoscyamine—pancreatitis	0.000959	0.0145	CcSEcCtD
Bosutinib—SRC—digestive system—pancreatitis	0.000958	0.00302	CbGeAlD
Bosutinib—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000952	0.0144	CcSEcCtD
Bosutinib—YES1—blood—pancreatitis	0.000949	0.00299	CbGeAlD
Bosutinib—STK10—blood—pancreatitis	0.00094	0.00297	CbGeAlD
Bosutinib—TAOK3—blood—pancreatitis	0.000936	0.00295	CbGeAlD
Bosutinib—Urticaria—Hyoscyamine—pancreatitis	0.000924	0.014	CcSEcCtD
Bosutinib—Body temperature increased—Hyoscyamine—pancreatitis	0.00092	0.0139	CcSEcCtD
Bosutinib—Abdominal pain—Hyoscyamine—pancreatitis	0.00092	0.0139	CcSEcCtD
Bosutinib—SRC—blood—pancreatitis	0.000913	0.00288	CbGeAlD
Bosutinib—PDGFRB—pancreas—pancreatitis	0.000893	0.00282	CbGeAlD
Bosutinib—CSF1R—digestive system—pancreatitis	0.00086	0.00271	CbGeAlD
Bosutinib—MAP2K5—blood—pancreatitis	0.000839	0.00265	CbGeAlD
Bosutinib—Asthenia—Hyoscyamine—pancreatitis	0.000835	0.0127	CcSEcCtD
Bosutinib—Pruritus—Hyoscyamine—pancreatitis	0.000823	0.0125	CcSEcCtD
Bosutinib—CSF1R—blood—pancreatitis	0.000819	0.00258	CbGeAlD
Bosutinib—Diarrhoea—Hyoscyamine—pancreatitis	0.000796	0.0121	CcSEcCtD
Bosutinib—ABL1—pancreas—pancreatitis	0.000796	0.00251	CbGeAlD
Bosutinib—Dizziness—Hyoscyamine—pancreatitis	0.00077	0.0117	CcSEcCtD
Bosutinib—PDGFRB—digestive system—pancreatitis	0.000763	0.00241	CbGeAlD
Bosutinib—Vomiting—Hyoscyamine—pancreatitis	0.00074	0.0112	CcSEcCtD
Bosutinib—Rash—Hyoscyamine—pancreatitis	0.000734	0.0111	CcSEcCtD
Bosutinib—Dermatitis—Hyoscyamine—pancreatitis	0.000733	0.0111	CcSEcCtD
Bosutinib—Headache—Hyoscyamine—pancreatitis	0.000729	0.0111	CcSEcCtD
Bosutinib—PDGFRB—blood—pancreatitis	0.000727	0.00229	CbGeAlD
Bosutinib—Nausea—Hyoscyamine—pancreatitis	0.000691	0.0105	CcSEcCtD
Bosutinib—ABL1—digestive system—pancreatitis	0.00068	0.00214	CbGeAlD
Bosutinib—ABL1—blood—pancreatitis	0.000648	0.00204	CbGeAlD
Bosutinib—Vandetanib—ALB—pancreatitis	0.000579	0.513	CrCbGaD
Bosutinib—Gefitinib—ALB—pancreatitis	0.00055	0.487	CrCbGaD
Bosutinib—ABCB1—islet of Langerhans—pancreatitis	0.000352	0.00111	CbGeAlD
Bosutinib—CYP3A4—digestive system—pancreatitis	0.000299	0.000942	CbGeAlD
Bosutinib—CYP3A4—blood—pancreatitis	0.000284	0.000898	CbGeAlD
Bosutinib—ABCB1—pancreas—pancreatitis	0.000247	0.000781	CbGeAlD
Bosutinib—ABCB1—digestive system—pancreatitis	0.000211	0.000667	CbGeAlD
Bosutinib—ABCB1—blood—pancreatitis	0.000201	0.000635	CbGeAlD
Bosutinib—RPS6KB1—Signaling Pathways—NRAS—pancreatitis	4.93e-06	8.01e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—NRAS—pancreatitis	4.93e-06	8.01e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—pancreatitis	4.92e-06	7.99e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—NRAS—pancreatitis	4.91e-06	7.98e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—INS—pancreatitis	4.91e-06	7.97e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—pancreatitis	4.91e-06	7.96e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—pancreatitis	4.89e-06	7.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—INS—pancreatitis	4.88e-06	7.93e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—HRAS—pancreatitis	4.87e-06	7.91e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—pancreatitis	4.86e-06	7.88e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—MDM2—pancreatitis	4.86e-06	7.88e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—pancreatitis	4.83e-06	7.84e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—NRAS—pancreatitis	4.81e-06	7.81e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—pancreatitis	4.8e-06	7.8e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—NRAS—pancreatitis	4.79e-06	7.78e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HRAS—pancreatitis	4.79e-06	7.77e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SPP1—pancreatitis	4.78e-06	7.77e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—LEP—pancreatitis	4.78e-06	7.77e-06	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HRAS—pancreatitis	4.76e-06	7.72e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—pancreatitis	4.76e-06	7.72e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—NRAS—pancreatitis	4.75e-06	7.72e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—pancreatitis	4.75e-06	7.72e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—pancreatitis	4.75e-06	7.72e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—KRAS—pancreatitis	4.74e-06	7.7e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—pancreatitis	4.74e-06	7.7e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—NRAS—pancreatitis	4.74e-06	7.69e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CASP3—pancreatitis	4.72e-06	7.66e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—HRAS—pancreatitis	4.72e-06	7.66e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—pancreatitis	4.72e-06	7.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—NRAS—pancreatitis	4.71e-06	7.65e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—pancreatitis	4.68e-06	7.6e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MDM2—pancreatitis	4.66e-06	7.56e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—NRAS—pancreatitis	4.65e-06	7.55e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CXCL8—pancreatitis	4.64e-06	7.54e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—KRAS—pancreatitis	4.64e-06	7.53e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—pancreatitis	4.58e-06	7.44e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—pancreatitis	4.58e-06	7.44e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—pancreatitis	4.58e-06	7.44e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—KRAS—pancreatitis	4.57e-06	7.42e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—HRAS—pancreatitis	4.56e-06	7.41e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GCG—pancreatitis	4.56e-06	7.39e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—pancreatitis	4.55e-06	7.39e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—NRAS—pancreatitis	4.54e-06	7.37e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—pancreatitis	4.52e-06	7.34e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—NRAS—pancreatitis	4.48e-06	7.27e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HRAS—pancreatitis	4.48e-06	7.27e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CASP3—pancreatitis	4.45e-06	7.22e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—KRAS—pancreatitis	4.44e-06	7.21e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—pancreatitis	4.42e-06	7.17e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—KRAS—pancreatitis	4.41e-06	7.15e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—HRAS—pancreatitis	4.39e-06	7.12e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—NRAS—pancreatitis	4.37e-06	7.1e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—pancreatitis	4.37e-06	7.09e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—NRAS—pancreatitis	4.35e-06	7.06e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MDM2—pancreatitis	4.34e-06	7.05e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—KRAS—pancreatitis	4.33e-06	7.04e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—pancreatitis	4.32e-06	7.01e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—MDM2—pancreatitis	4.3e-06	6.98e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—pancreatitis	4.29e-06	6.96e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—KRAS—pancreatitis	4.24e-06	6.89e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—KRAS—pancreatitis	4.24e-06	6.89e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—INS—pancreatitis	4.24e-06	6.88e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MDM2—pancreatitis	4.24e-06	6.88e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEP—pancreatitis	4.23e-06	6.87e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NRAS—pancreatitis	4.23e-06	6.87e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—KRAS—pancreatitis	4.23e-06	6.87e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—pancreatitis	4.22e-06	6.85e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HRAS—pancreatitis	4.22e-06	6.84e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HRAS—pancreatitis	4.21e-06	6.84e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—pancreatitis	4.2e-06	6.81e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	4.19e-06	6.81e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—pancreatitis	4.18e-06	6.78e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NRAS—pancreatitis	4.17e-06	6.77e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—pancreatitis	4.17e-06	6.77e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MDM2—pancreatitis	4.15e-06	6.73e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—pancreatitis	4.14e-06	6.73e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—KRAS—pancreatitis	4.14e-06	6.72e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—KRAS—pancreatitis	4.12e-06	6.69e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NRAS—pancreatitis	4.09e-06	6.64e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—KRAS—pancreatitis	4.09e-06	6.64e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—INS—pancreatitis	4.09e-06	6.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MDM2—pancreatitis	4.08e-06	6.63e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—KRAS—pancreatitis	4.08e-06	6.62e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—pancreatitis	4.06e-06	6.6e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MDM2—pancreatitis	4.06e-06	6.59e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CXCL8—pancreatitis	4.06e-06	6.59e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—KRAS—pancreatitis	4.06e-06	6.58e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—A2M—pancreatitis	4.05e-06	6.57e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—pancreatitis	4.04e-06	6.56e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—pancreatitis	4.04e-06	6.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—HRAS—pancreatitis	4.03e-06	6.55e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—pancreatitis	4.02e-06	6.53e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—KRAS—pancreatitis	4e-06	6.5e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CXCL8—pancreatitis	3.96e-06	6.43e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NRAS—pancreatitis	3.96e-06	6.42e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HRAS—pancreatitis	3.94e-06	6.4e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—NRAS—pancreatitis	3.94e-06	6.4e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—pancreatitis	3.93e-06	6.38e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—KRAS—pancreatitis	3.91e-06	6.34e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HRAS—pancreatitis	3.89e-06	6.31e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CASP3—pancreatitis	3.88e-06	6.31e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CXCL8—pancreatitis	3.88e-06	6.3e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—pancreatitis	3.88e-06	6.29e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—pancreatitis	3.86e-06	6.27e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—KRAS—pancreatitis	3.86e-06	6.26e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—pancreatitis	3.82e-06	6.2e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—pancreatitis	3.8e-06	6.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CASP3—pancreatitis	3.79e-06	6.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—NRAS—pancreatitis	3.78e-06	6.13e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—pancreatitis	3.78e-06	6.13e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—HRAS—pancreatitis	3.77e-06	6.13e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—KRAS—pancreatitis	3.76e-06	6.11e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HRAS—pancreatitis	3.74e-06	6.08e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—KRAS—pancreatitis	3.74e-06	6.08e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NRAS—pancreatitis	3.73e-06	6.05e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—pancreatitis	3.72e-06	6.04e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CASP3—pancreatitis	3.71e-06	6.03e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALDH2—pancreatitis	3.7e-06	6.01e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HRAS—pancreatitis	3.68e-06	5.98e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—pancreatitis	3.68e-06	5.97e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CASP3—pancreatitis	3.65e-06	5.93e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—NRAS—pancreatitis	3.64e-06	5.91e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—KRAS—pancreatitis	3.64e-06	5.91e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CASP3—pancreatitis	3.63e-06	5.9e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—INS—pancreatitis	3.62e-06	5.87e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—pancreatitis	3.61e-06	5.86e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HRAS—pancreatitis	3.61e-06	5.86e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HRAS—pancreatitis	3.61e-06	5.86e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HRAS—pancreatitis	3.6e-06	5.84e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—KRAS—pancreatitis	3.59e-06	5.83e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—pancreatitis	3.58e-06	5.82e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—LPL—pancreatitis	3.57e-06	5.8e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—pancreatitis	3.56e-06	5.78e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MDM2—pancreatitis	3.53e-06	5.73e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—pancreatitis	3.53e-06	5.73e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—KRAS—pancreatitis	3.52e-06	5.72e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—HRAS—pancreatitis	3.52e-06	5.72e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—pancreatitis	3.51e-06	5.7e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HRAS—pancreatitis	3.5e-06	5.69e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—NRAS—pancreatitis	3.49e-06	5.67e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HRAS—pancreatitis	3.48e-06	5.65e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—HRAS—pancreatitis	3.47e-06	5.63e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—pancreatitis	3.46e-06	5.62e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—pancreatitis	3.45e-06	5.61e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—pancreatitis	3.45e-06	5.61e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HRAS—pancreatitis	3.45e-06	5.6e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—pancreatitis	3.44e-06	5.59e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—KRAS—pancreatitis	3.41e-06	5.53e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—HRAS—pancreatitis	3.4e-06	5.52e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MDM2—pancreatitis	3.4e-06	5.52e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—KRAS—pancreatitis	3.39e-06	5.51e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—pancreatitis	3.38e-06	5.49e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—pancreatitis	3.37e-06	5.47e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—pancreatitis	3.35e-06	5.44e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—pancreatitis	3.33e-06	5.4e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—HRAS—pancreatitis	3.32e-06	5.39e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—pancreatitis	3.32e-06	5.39e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—pancreatitis	3.3e-06	5.36e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—pancreatitis	3.3e-06	5.35e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HRAS—pancreatitis	3.28e-06	5.32e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NRAS—pancreatitis	3.26e-06	5.29e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—pancreatitis	3.26e-06	5.29e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—KRAS—pancreatitis	3.25e-06	5.28e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NRAS—pancreatitis	3.22e-06	5.23e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—KRAS—pancreatitis	3.21e-06	5.21e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—HRAS—pancreatitis	3.2e-06	5.19e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—HRAS—pancreatitis	3.18e-06	5.17e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—pancreatitis	3.18e-06	5.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NRAS—pancreatitis	3.18e-06	5.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—pancreatitis	3.18e-06	5.16e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CASP3—pancreatitis	3.16e-06	5.13e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—pancreatitis	3.14e-06	5.09e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—KRAS—pancreatitis	3.13e-06	5.09e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NRAS—pancreatitis	3.11e-06	5.05e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HRAS—pancreatitis	3.1e-06	5.02e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NRAS—pancreatitis	3.06e-06	4.97e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—pancreatitis	3.06e-06	4.97e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HRAS—pancreatitis	3.05e-06	4.96e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NRAS—pancreatitis	3.05e-06	4.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—pancreatitis	3.05e-06	4.95e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CASP3—pancreatitis	3.04e-06	4.94e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—pancreatitis	3.03e-06	4.91e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MDM2—pancreatitis	3.01e-06	4.89e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—KRAS—pancreatitis	3.01e-06	4.88e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—pancreatitis	3e-06	4.86e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HRAS—pancreatitis	2.99e-06	4.86e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—pancreatitis	2.96e-06	4.81e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—pancreatitis	2.95e-06	4.79e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—pancreatitis	2.92e-06	4.74e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HRAS—pancreatitis	2.9e-06	4.7e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—pancreatitis	2.89e-06	4.69e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—HRAS—pancreatitis	2.89e-06	4.68e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—pancreatitis	2.87e-06	4.65e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—pancreatitis	2.85e-06	4.62e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—pancreatitis	2.83e-06	4.6e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—pancreatitis	2.81e-06	4.57e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCG—pancreatitis	2.81e-06	4.56e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—KRAS—pancreatitis	2.8e-06	4.55e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—KRAS—pancreatitis	2.77e-06	4.5e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—pancreatitis	2.77e-06	4.5e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—HRAS—pancreatitis	2.76e-06	4.49e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—pancreatitis	2.76e-06	4.48e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—KRAS—pancreatitis	2.74e-06	4.44e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HRAS—pancreatitis	2.73e-06	4.43e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CASP3—pancreatitis	2.69e-06	4.37e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—KRAS—pancreatitis	2.68e-06	4.35e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—HRAS—pancreatitis	2.66e-06	4.32e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NRAS—pancreatitis	2.65e-06	4.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—pancreatitis	2.65e-06	4.3e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—KRAS—pancreatitis	2.64e-06	4.28e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—KRAS—pancreatitis	2.62e-06	4.26e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARG—pancreatitis	2.61e-06	4.24e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—pancreatitis	2.61e-06	4.24e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INS—pancreatitis	2.56e-06	4.16e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—HRAS—pancreatitis	2.55e-06	4.15e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NRAS—pancreatitis	2.55e-06	4.14e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—pancreatitis	2.55e-06	4.14e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—pancreatitis	2.46e-06	3.99e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—pancreatitis	2.44e-06	3.97e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HRAS—pancreatitis	2.38e-06	3.87e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—pancreatitis	2.37e-06	3.85e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—HRAS—pancreatitis	2.36e-06	3.83e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—pancreatitis	2.35e-06	3.81e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HRAS—pancreatitis	2.32e-06	3.77e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—pancreatitis	2.28e-06	3.7e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KRAS—pancreatitis	2.28e-06	3.7e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HRAS—pancreatitis	2.28e-06	3.7e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NRAS—pancreatitis	2.26e-06	3.66e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—pancreatitis	2.26e-06	3.66e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HRAS—pancreatitis	2.24e-06	3.64e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HRAS—pancreatitis	2.23e-06	3.62e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—pancreatitis	2.23e-06	3.61e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LPL—pancreatitis	2.2e-06	3.58e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KRAS—pancreatitis	2.19e-06	3.56e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—pancreatitis	2.18e-06	3.54e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—pancreatitis	2.14e-06	3.48e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—pancreatitis	2.13e-06	3.46e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—pancreatitis	2.1e-06	3.41e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—pancreatitis	2.05e-06	3.33e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KRAS—pancreatitis	1.94e-06	3.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HRAS—pancreatitis	1.94e-06	3.14e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HRAS—pancreatitis	1.87e-06	3.03e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—pancreatitis	1.85e-06	3.01e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—pancreatitis	1.79e-06	2.9e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HRAS—pancreatitis	1.65e-06	2.68e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARG—pancreatitis	1.61e-06	2.61e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—pancreatitis	1.58e-06	2.57e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INS—pancreatitis	1.58e-06	2.56e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—pancreatitis	1.45e-06	2.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—pancreatitis	1.26e-06	2.05e-06	CbGpPWpGaD
